Abstract

Objective To investigate the development of painless bronchoscope diagnosis and treatment under general anesthesia in five provinces and cities in China. Methods From December 2018 to February 2019, a self-designed electronic questionnaire was sent to related personnels in a department of anesthesiology in hospitals within the range of survey through the WeChat platform.The survey mainly included three aspects: basic information of hospital, development of bronchoscope diagnosis and treatment under general anesthesia and the specific management plan. Results Questionnaires were sent to 326 hospitals in total, and 261 hospitals responded with a response rate of 80.06%.Among the 261 hospitals involved in the survey, 34 hospitals responded that no related diseases were found, and thus the number of valid questionnaires was 227, and the rate of valid questionnaires was 87.0%.Among the 261 hospitals, 161 hospitals were tertiary hospitals, and 66 hospitals were secondary hospitals, with a constituent ratio of 70.9% to 29.1%.The average development rate of painless bronchoscopy was 34.8%, the highest rate was 54.0% in Beijing, and the lowest rate was 27.5% in Hebei province.The average development rate of painless bronchoscopy was significantly higher in tertiary hospitals than in secondary hospitals (P 0.05); the number of hospitals applying sevoflurane was larger as compared with that of hospitals applying desflurane(P 0.05). Conclusion At present, the development rate of painless bronchoscopy in China is lower, and the greatest difficulty in further development is the shortage of personnel.Bronchoscope diagnosis and treatment under laryngeal mask or under monitoring anesthesia is the most commonly used method in clinic, and general anesthesia under tracheal intubation is more suitable for highly difficult bronchoscope diagnosis and treatment.Opioids combined with propofol is the most commonly used anesthesia method. Key words: Bronchoscopy; Surveys and questionnaires

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call